{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038029","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2023-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.008775+00:00","generated_at":"2026-06-09T13:50:42.779035+00:00","sec_items":["5.03"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Bone Biologics reduces stockholder quorum requirement from majority to one-third","bullets":["Board approved Bylaw Amendment reducing quorum from majority to at least one-third of outstanding voting power.","Amendment effective immediately as of October 20, 2023.","Change intended to facilitate holding stockholder meetings with lower attendance threshold."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038029","json":"https://secwatch.observer/filing/0001493152-23-038029.json","markdown":"https://secwatch.observer/filing/0001493152-23-038029.md","text":"https://secwatch.observer/filing/0001493152-23-038029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223038029/0001493152-23-038029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223038029/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T13:50:42.779035+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0575de763a6fd047b785bcf2f7315c6fddd85cce","claim":"Bone Biologics Corp: Reduced quorum requirement for stockholder meetings from majority to at least one-third in voting power (effective 2023-10-20).","evidence_excerpt":"On October 20, 2023, the Board of Directors of Bone Biologics Corporation (the “Company”) approved an amendment to the Company’s Amended and Restated Bylaws (the “Amendment”). The Amendment, which became effective immediately, reduces the quorum requirement at all meetings of the Company’s stockholders from a majority in voting power of the Company’s common stock issued and outstanding and entitled to vote at the meeting to at least one-third in voting power of the Company’s common stock issued and outstanding and entitled to vote at the meeting.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1419554/000149315223038029/0001493152-23-038029-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-10-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}